M
Mary Chester M. Wasko
Researcher at Allegheny Health Network
Publications - 64
Citations - 6104
Mary Chester M. Wasko is an academic researcher from Allegheny Health Network. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 32, co-authored 63 publications receiving 5775 citations. Previous affiliations of Mary Chester M. Wasko include Temple University & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Joan M. Bathon,Richard J. Martin,Roy Fleischmann,John Tesser,Michael Schiff,Edward C. Keystone,Mark C. Genovese,Mary Chester M. Wasko,Larry W. Moreland,Arthur L. Weaver,Joseph A. Markenson,Barbara K. Finck +11 more
TL;DR: Subcutaneous [corrected] etanercept acted more rapidly to decrease symptoms and slow joint damage in patients with early active rheumatoid arthritis.
Journal ArticleDOI
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Mark C. Genovese,Joan M. Bathon,Richard J. Martin,Roy Fleischmann,John Tesser,Michael Schiff,Edward C. Keystone,Mary Chester M. Wasko,Larry W. Moreland,Arthur L. Weaver,Joseph A. Markenson,Grant W. Cannon,George Spencer-Green,Barbara K. Finck +13 more
TL;DR: Etanercept as monotherapy was safe and was superior to MTX in reducing disease activity, arresting structural damage, and decreasing disability over 2 years in patients with early, aggressive RA.
Journal ArticleDOI
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
Principal Investigator: Christopher H. Evans,Henry J. Mankin,Co-Principal Investigator: Paul D. Robbins,Co-Investigator: Steve C. Ghivizzani,James H. Herndon,Richard Kang,John A. Barranger,Elaine M. Elders,Matthew M. Tomaino,Mary Chester M. Wasko,Simon C. Watkins,Theresa L. Whiteside,Consultants: Joseph C. Glorioso,Michael T. Lotze,Timothy M. Wright +14 more
Journal ArticleDOI
Hydroxychloroquine and Risk of Diabetes in Patients With Rheumatoid Arthritis
Mary Chester M. Wasko,Helen B. Hubert,Vijaya B. Lingala,Jennifer R. Elliott,Michael E. Luggen,James F. Fries,Michael M. Ward +6 more
TL;DR: Among patients with rheumatoid arthritis, use of hydroxychloroquine is associated with a reduced risk of diabetes.
Journal ArticleDOI
Cardiovascular disease in autoimmune rheumatic diseases
Ivana Hollan,Pier Luigi Meroni,Joseph M. Ahearn,J. W. Cohen Tervaert,Sam Curran,Carl S. Goodyear,Knut Hestad,Knut Hestad,Bashar Kahaleh,Marcello P. Riggio,Kelly J. Shields,Mary Chester M. Wasko +11 more
TL;DR: Based on biopsy findings, also inflammation in the myocardium and small vessels may contribute to premature CVD in ARDs (cardiac ischemia and heart failure), and drugs targeting immunologic factors participating in the subintimal inflammation might have a protective effect on CVD.